Quell Therapeutics
ID: 17657879Cell therapy firm specializing in developing treatments using advanced cellular technology.
6
Funding Rounds
$474.7m
Money raised
Recent Funding Rounds
Overview
Cell therapy firm specializing in developing treatments using advanced cellular technology.
- Business model: B2B
- Headquarters: London
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Quell Therapeutics has raised a total of $314.7m in funding over 6 rounds.
Key Insights:
- Quell Therapeutics Series B round, November 2021: $156m
- Quell Therapeutics Series A (extension) , February 2021: $35.7m
- Quell Therapeutics February 2021 Series A Funding Round: $40m
- Quell Therapeutics Seed round, December 2020: $3m
- Quell Therapeutics Series A round, May 2019: $35m
- Quell Therapeutics May 2019 Series A Funding Round: $45m
Industries
Quell Therapeutics is active in the following industries: